{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:01:49Z","timestamp":1789974109199,"version":"4.0.1"},"reference-count":147,"publisher":"China Science Publishing & Media Ltd.","issue":"9","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2026,9,1]]},"DOI":"10.3724\/abbs.2026138","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T09:36:28Z","timestamp":1784885788000},"page":"1931-1948","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["Dynamic subpopulations and spatial interactions of hepatic stellate cells and cancer-associated fibroblasts in liver cancer"],"prefix":"10.3724","volume":"58","author":[{"given":"Wenjing","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"e70090","DOI":"10.3322\/caac.70090","volume":"76","author":"Sung H","year":"2026","unstructured":"Sung H, Filho AM, Laversanne M, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries. CA Cancer J Clin, 2026, 76:","journal-title":"CA Cancer J Clin"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1002\/cncr.34479","volume":"128","author":"Cronin KA","year":"2022","unstructured":"Cronin KA, Scott S, Firth AU, Sung H, Henley SJ, Sherman RL, Siegel RL. Annual report to the nation on the status of cancer, part 1: national cancer statistics. Cancer, 2022, 128: 4251-4284.","journal-title":"Cancer"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","volume":"76","author":"Nagtegaal ID","year":"2020","unstructured":"Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, Washington KM. The 2019 WHO classification of tumours of the digestive system. Histopathology, 2020, 76: 182-188.","journal-title":"Histopathology"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"1133308","DOI":"10.3389\/fimmu.2023.1133308","volume":"14","author":"Chen C","year":"2023","unstructured":"Chen C, Wang Z, Ding Y, Qin Y. Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma. Front Immunol, 2023, 14:","journal-title":"Front Immunol"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","volume":"348","author":"Joyce JA","year":"2015","unstructured":"Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Science, 2015, 348: 74-80.","journal-title":"Science"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jhep.2013.04.033","volume":"59","author":"H\u00f6chst B","year":"2013","unstructured":"H\u00f6chst B, Schildberg FA, Sauerborn P, G\u00e4bel YA, Gevensleben H, Goltz D, Heukamp LC. Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion. J Hepatol, 2013, 59: 528-535.","journal-title":"J Hepatol"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.4049\/jimmunol.1201937","volume":"190","author":"Dunham RM","year":"2013","unstructured":"Dunham RM, Thapa M, Velazquez VM, Elrod EJ, Denning TL, Pulendran B, Grakoui A. Hepatic stellate cells preferentially induce Foxp3+ regulatory T cells by production of retinoic acid. J Immunol, 2013, 190: 2009-2016.","journal-title":"J Immunol"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/onc.2016.273","volume":"36","author":"Deng Y","year":"2016","unstructured":"Deng Y, Cheng J, Fu B, Liu W, Chen G, Zhang Q, Yang Y. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells. Oncogene, 2016, 36: 1090-1101.","journal-title":"Oncogene"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/nrclinonc.2018.9","volume":"15","author":"Khan KA","year":"2018","unstructured":"Khan KA, Kerbel RS. Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa. Nat Rev Clin Oncol, 2018, 15: 310-324.","journal-title":"Nat Rev Clin Oncol"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"5449","DOI":"10.1158\/1078-0432.CCR-18-1543","volume":"25","author":"Rahma OE","year":"2019","unstructured":"Rahma OE, Hodi FS. The intersection between tumor angiogenesis and immune suppression. Clin Cancer Res, 2019, 25: 5449-5457.","journal-title":"Clin Cancer Res"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1084\/jem.20140559","volume":"212","author":"Voron T","year":"2015","unstructured":"Voron T, Colussi O, Marcheteau E, Pernot S, Nizard M, Pointet AL, Latreche S. VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors. J Exp Med, 2015, 212: 139-148.","journal-title":"J Exp Med"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.semcancer.2018.06.002","volume":"52","author":"Missiaen R","year":"2018","unstructured":"Missiaen R, Mazzone M, Bergers G. The reciprocal function and regulation of tumor vessels and immune cells offers new therapeutic opportunities in cancer. Semin Cancer Biol, 2018, 52: 107-116.","journal-title":"Semin Cancer Biol"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1136\/gutjnl-2017-314032","volume":"67","author":"Zhou J","year":"2018","unstructured":"Zhou J, Liu M, Sun H, Feng Y, Xu L, Chan AWH, Tong JH. Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy. Gut, 2018, 67: 931-944.","journal-title":"Gut"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"e1349587","DOI":"10.1080\/2162402X.2017.1349587","volume":"6","author":"Zha H","year":"2017","unstructured":"Zha H, Han X, Zhu Y, Yang F, Li Y, Li Q, Guo B. Blocking C5aR signaling promotes the anti-tumor efficacy of PD-1\/PD-L1 blockade. OncoImmunology, 2017, 6:","journal-title":"OncoImmunology"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/gutjnl-2018-317257","volume":"69","author":"Liu M","year":"2020","unstructured":"Liu M, Zhou J, Liu X, Feng Y, Yang W, Wu F, Cheung OKW. Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma. Gut, 2020, 69: 365-379.","journal-title":"Gut"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"4284","DOI":"10.1200\/JCO.2015.62.8719","volume":"33","author":"Catenacci DVT","year":"2015","unstructured":"Catenacci DVT, Junttila MR, Karrison T, Bahary N, Horiba MN, Nattam SR, Marsh R. Randomized phase Ib\/II study of gemcitabine plus placebo or vismodegib, a hedgehog pathway inhibitor, in patients with metastatic pancreatic cancer. J Clin Oncol, 2015, 33: 4284-4292.","journal-title":"J Clin Oncol"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/MPA.0000000000000458","volume":"45","author":"Ko AH","year":"2016","unstructured":"Ko AH, LoConte N, Tempero MA, Walker EJ, Kate Kelley R, Lewis S, Chang WC. A phase I study of FOLFIRINOX plus IPI-926, a hedgehog pathway inhibitor, for advanced pancreatic adenocarcinoma. Pancreas, 2016, 45: 370-375.","journal-title":"Pancreas"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1200\/JCO.18.01295","volume":"37","author":"Ramanathan RK","year":"2019","unstructured":"Ramanathan RK, McDonough SL, Philip PA, Hingorani SR, Lacy J, Kortmansky JS, Thumar J. Phase IB\/II randomized study of FOLFIRINOX plus pegylated recombinant human hyaluronidase versus FOLFIRINOX alone in patients with metastatic pancreatic adenocarcinoma: SWOG S1313. J Clin Oncol, 2019, 37: 1062-1069.","journal-title":"J Clin Oncol"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1152\/physrev.00013.2007","volume":"88","author":"Friedman SL","year":"2008","unstructured":"Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev, 2008, 88: 125-172.","journal-title":"Physiol Rev"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1172\/JCI116451","volume":"91","author":"Maher JJ","year":"1993","unstructured":"Maher JJ. Cell-specific expression of hepatocyte growth factor in liver. Upregulation in sinusoidal endothelial cells after carbon tetrachloride. J Clin Invest, 1993, 91: 2244-2252.","journal-title":"J Clin Invest"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/hep.1840150103","volume":"15","author":"Schirmacher P","year":"1992","unstructured":"Schirmacher P, Geerts A, Pietrangelo A, Dienes HP, Rogler CE. Hepatocyte growth factor\/hepatopoietin A is expressed in fat-storing cells from rat liver but not myofibroblast-like cells derived from fat-storing cells. Hepatology, 1992, 15: 5-11.","journal-title":"Hepatology"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1515\/cclm.1989.27.9.555","volume":"27","author":"Bachem MG","year":"1989","unstructured":"Bachem MG, Melchior R, Gressner AM. The role of thrombocytes in liver fibrogenesis: effects of platelet lysate and thrombocyte-derived growth factors on the mitogenic activity and glycosaminoglycan synthesis of cultured rat liver fat storing cells. Clin Chem Lab Med, 1989, 27: 555-565.","journal-title":"Clin Chem Lab Med"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1111\/j.1440-1746.2006.04585.x","volume":"21","author":"Friedman SL","year":"2006","unstructured":"Friedman SL. Transcriptional regulation of stellate cell activation. J Gastro Hepatol, 2006, 21: S79-S83.","journal-title":"J Gastro Hepatol"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"Tsuchida T","year":"2017","unstructured":"Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol, 2017, 14: 397-411.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1053\/j.gastro.2020.01.027","volume":"158","author":"Liu X","year":"2020","unstructured":"Liu X, Xu J, Rosenthal S, Zhang L, McCubbin R, Meshgin N, Shang L. Identification of lineage-specific transcription factors that prevent activation of hepatic stellate cells and promote fibrosis resolution. Gastroenterology, 2020, 158: 1728-1744.e14.","journal-title":"Gastroenterology"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"eadd3949","DOI":"10.1126\/scitranslmed.add3949","volume":"15","author":"Wang S","year":"2023","unstructured":"Wang S, Li K, Pickholz E, Dobie R, Matchett KP, Henderson NC, Carrico C. An autocrine signaling circuit in hepatic stellate cells underlies advanced fibrosis in nonalcoholic steatohepatitis. Sci Transl Med, 2023, 15:","journal-title":"Sci Transl Med"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1002\/hep.31848","volume":"74","author":"Wang SS","year":"2021","unstructured":"Wang SS, Tang XT, Lin M, Yuan J, Peng YJ, Yin X, Shang GG. Perivenous stellate cells are the main source of myofibroblasts and cancer-associated fibroblasts formed after chronic liver injuries. Hepatology, 2021, 74: 1578-1594.","journal-title":"Hepatology"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nrm809","volume":"3","author":"Tomasek JJ","year":"2002","unstructured":"Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol, 2002, 3: 349-363.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ccr.2009.12.041","volume":"17","author":"Erez N","year":"2010","unstructured":"Erez N, Truitt M, Olson P, Hanahan D. Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-\u03baB-dependent manner. Cancer Cell, 2010, 17: 135-147.","journal-title":"Cancer Cell"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ccr.2011.06.018","volume":"20","author":"Sanz-Moreno V","year":"2011","unstructured":"Sanz-Moreno V, Gaggioli C, Yeo M, Albrengues J, Wallberg F, Viros A, Hooper S. ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma. Cancer Cell, 2011, 20: 229-245.","journal-title":"Cancer Cell"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"Sahai E","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, Fearon D. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer, 2020, 20: 174-186.","journal-title":"Nat Rev Cancer"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s13046-018-0965-2","volume":"37","author":"Zhou Y","year":"2018","unstructured":"Zhou Y, Ren H, Dai B, Li J, Shang L, Huang J, Shi X. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts. J Exp Clin Cancer Res, 2018, 37:","journal-title":"J Exp Clin Cancer Res"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.ccell.2021.05.010","volume":"39","author":"Affo S","year":"2021","unstructured":"Affo S, Nair A, Brundu F, Ravichandra A, Bhattacharjee S, Matsuda M, Chin LK. Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations. Cancer Cell, 2021, 39:","journal-title":"Cancer Cell"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.jhep.2020.05.039","volume":"73","author":"Zhang M","year":"2020","unstructured":"Zhang M, Yang H, Wan L, Wang Z, Wang H, Ge C, Liu Y. Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma. J Hepatol, 2020, 73: 1118-1130.","journal-title":"J Hepatol"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","volume":"18","author":"Chen X","year":"2018","unstructured":"Chen X, Song E. Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discov, 2018, 18: 99-115.","journal-title":"Nat Rev Drug Discov"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"4966","DOI":"10.1073\/pnas.0401064101","volume":"101","author":"Kuperwasser C","year":"2004","unstructured":"Kuperwasser C, Chavarria T, Wu M, Magrane G, Gray JW, Carey L, Richardson A. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci USA, 2004, 101: 4966-4971.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.celrep.2016.04.019","volume":"15","author":"Lau EYT","year":"2016","unstructured":"Lau EYT, Lo J, Cheng BYL, Ma MKF, Lee JMF, Ng JKY, Chai S. Cancer-associated fibroblasts regulate tumor-initiating cell plasticity in hepatocellular carcinoma through c-Met\/FRA1\/HEY1 signaling. Cell Rep, 2016, 15: 1175-1189.","journal-title":"Cell Rep"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrc.2017.51","volume":"17","author":"De Palma M","year":"2017","unstructured":"De Palma M, Biziato D, Petrova TV. Microenvironmental regulation of tumour angiogenesis. Nat Rev Cancer, 2017, 17: 457-474.","journal-title":"Nat Rev Cancer"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/ncb2122","volume":"12","author":"Astin JW","year":"2010","unstructured":"Astin JW, Batson J, Kadir S, Charlet J, Persad RA, Gillatt D, Oxley JD. Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells. Nat Cell Biol, 2010, 12: 1194-1204.","journal-title":"Nat Cell Biol"},{"key":"CITATION40","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1096\/fj.03-1110fje","volume":"18","author":"De Wever O","year":"2004","unstructured":"De Wever O, Nguyen QD, Van Hoorde L, Bracke M, Bruyneel E, Gespach C, Mareel M. Tenascin-C and SF\/HGF produced by myofibroblasts in vitro provide convergent proinvasive signals to human colon cancer cells through RhoA and Rac. FASEB J, 2004, 18: 1016-1018.","journal-title":"FASEB J"},{"key":"CITATION41","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.cell.2016.03.029","volume":"165","author":"Tape CJ","year":"2016","unstructured":"Tape CJ, Ling S, Dimitriadi M, McMahon KM, Worboys JD, Leong HS, Norrie IC. Oncogenic KRAS regulates tumor cell signaling via stromal reciprocation. Cell, 2016, 165: 910-920.","journal-title":"Cell"},{"key":"CITATION42","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ccr.2005.08.010","volume":"8","author":"Paszek MJ","year":"2005","unstructured":"Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A, Reinhart-King CA. Tensional homeostasis and the malignant phenotype. Cancer Cell, 2005, 8: 241-254.","journal-title":"Cancer Cell"},{"key":"CITATION43","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/ncb1658","volume":"9","author":"Gaggioli C","year":"2007","unstructured":"Gaggioli C, Hooper S, Hidalgo-Carcedo C, Grosse R, Marshall JF, Harrington K, Sahai E. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol, 2007, 9: 1392-1400.","journal-title":"Nat Cell Biol"},{"key":"CITATION44","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nature10694","volume":"481","author":"Malanchi I","year":"2011","unstructured":"Malanchi I, Santamaria-Mart\u00ednez A, Susanto E, Peng H, Lehr HA, Delaloye JF, Huelsken J. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature, 2011, 481: 85-89.","journal-title":"Nature"},{"key":"CITATION45","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41419-018-0458-4","volume":"9","author":"Cheng Y","year":"2018","unstructured":"Cheng Y, Li H, Deng Y, Tai Y, Zeng K, Zhang Y, Liu W. Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma. Cell Death Dis, 2018, 9:","journal-title":"Cell Death Dis"},{"key":"CITATION46","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.canlet.2011.12.020","volume":"318","author":"Li T","year":"2012","unstructured":"Li T, Yang Y, Hua X, Wang G, Liu W, Jia C, Tai Y. Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO. Cancer Lett, 2012, 318: 154-161.","journal-title":"Cancer Lett"},{"key":"CITATION47","doi-asserted-by":"publisher","first-page":"e198","DOI":"10.1038\/oncsis.2016.7","volume":"5","author":"Cheng J","year":"2016","unstructured":"Cheng J, Deng Y, Yi H, Wang G, Fu B, Chen W, Liu W. Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation. Oncogenesis, 2016, 5:","journal-title":"Oncogenesis"},{"key":"CITATION48","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41420-021-00696-6","volume":"7","author":"Wang JW","year":"2021","unstructured":"Wang JW, Ma L, Liang Y, Yang XJ, Wei S, Peng H, Qiu SP. RCN1 induces sorafenib resistance and malignancy in hepatocellular carcinoma by activating c-MYC signaling via the IRE1\u03b1\u2013XBP1s pathway. Cell Death Discov, 2021, 7:","journal-title":"Cell Death Discov"},{"key":"CITATION49","doi-asserted-by":"publisher","first-page":"856","DOI":"10.21037\/atm-20-1038","volume":"8","author":"Peng H","year":"2020","unstructured":"Peng H, Xue R, Ju Z, Qiu J, Wang J, Yan W, Gan X. Cancer-associated fibroblasts enhance the chemoresistance of CD73+ hepatocellular carcinoma cancer cells via HGF-Met-ERK1\/2 pathway. Ann Transl Med, 2020, 8:","journal-title":"Ann Transl Med"},{"key":"CITATION50","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1158\/1078-0432.CCR-15-2851","volume":"23","author":"Brechbuhl HM","year":"2017","unstructured":"Brechbuhl HM, Finlay-Schultz J, Yamamoto TM, Gillen AE, Cittelly DM, Tan AC, Sams SB. Fibroblast subtypes regulate responsiveness of luminal breast cancer to estrogen. Clin Cancer Res, 2017, 23: 1710-1721.","journal-title":"Clin Cancer Res"},{"key":"CITATION51","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/hep4.1854","volume":"6","author":"Andrews TS","year":"2022","unstructured":"Andrews TS, Atif J, Liu JC, Perciani CT, Ma XZ, Thoeni C, Slyper M. Single-cell, single-nucleus, and spatial RNA sequencing of the human liver identifies cholangiocyte and mesenchymal heterogeneity. Hepatol Commun, 2022, 6: 821-840.","journal-title":"Hepatol Commun"},{"key":"CITATION52","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41586-022-05289-6","volume":"610","author":"Filliol A","year":"2022","unstructured":"Filliol A, Saito Y, Nair A, Dapito DH, Yu LX, Ravichandra A, Bhattacharjee S. Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis. Nature, 2022, 610: 356-365.","journal-title":"Nature"},{"key":"CITATION53","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1016\/j.celrep.2019.10.024","volume":"29","author":"Dobie R","year":"2019","unstructured":"Dobie R, Wilson-Kanamori JR, Henderson BEP, Smith JR, Matchett KP, Portman JR, Wallenborg K. Single-cell transcriptomics uncovers zonation of function in the mesenchyme during liver fibrosis. Cell Rep, 2019, 29: 1832-1847.e8.","journal-title":"Cell Rep"},{"key":"CITATION54","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/hep.31743","volume":"74","author":"Rosenthal SB","year":"2021","unstructured":"Rosenthal SB, Liu X, Ganguly S, Dhar D, Pasillas MP, Ricciardelli E, Li RZ. Heterogeneity of HSCs in a mouse model of NASH. Hepatology, 2021, 74: 667-685.","journal-title":"Hepatology"},{"key":"CITATION55","doi-asserted-by":"publisher","first-page":"100278","DOI":"10.1016\/j.jhepr.2021.100278","volume":"3","author":"Payen VL","year":"2021","unstructured":"Payen VL, Lavergne A, Alevra Sarika N, Colonval M, Karim L, Deckers M, Najimi M. Single-cell RNA sequencing of human liver reveals hepatic stellate cell heterogeneity. JHEP Rep, 2021, 3:","journal-title":"JHEP Rep"},{"key":"CITATION56","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3390\/cells8050503","volume":"8","author":"Krenkel O","year":"2019","unstructured":"Krenkel O, Hundertmark J, Ritz TP, Weiskirchen R, Tacke F. Single cell RNA sequencing identifies subsets of hepatic stellate cells and myofibroblasts in liver fibrosis. Cells, 2019, 8:","journal-title":"Cells"},{"key":"CITATION57","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.3390\/cells10082129","volume":"10","author":"Zhang W","year":"2021","unstructured":"Zhang W, Conway SJ, Liu Y, Snider P, Chen H, Gao H, Liu Y. Heterogeneity of hepatic stellate cells in fibrogenesis of the liver: insights from single-cell transcriptomic analysis in liver injury. Cells, 2021, 10:","journal-title":"Cells"},{"key":"CITATION58","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1002\/hep.31987","volume":"74","author":"Yang W","year":"2021","unstructured":"Yang W, He H, Wang T, Su N, Zhang F, Jiang K, Zhu J. Single-cell transcriptomic analysis reveals a hepatic stellate cell-activation roadmap and myofibroblast origin during liver fibrosis in mice. Hepatology, 2021, 74: 2774-2790.","journal-title":"Hepatology"},{"key":"CITATION59","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.molcel.2019.07.028","volume":"75","author":"Xiong X","year":"2019","unstructured":"Xiong X, Kuang H, Ansari S, Liu T, Gong J, Wang S, Zhao XY. Landscape of intercellular crosstalk in healthy and NASH liver revealed by single-cell secretome gene analysis. Mol Cell, 2019, 75: 644-660.e5.","journal-title":"Mol Cell"},{"key":"CITATION60","doi-asserted-by":"publisher","first-page":"103233","DOI":"10.1016\/j.isci.2021.103233","volume":"24","author":"Su Q","year":"2021","unstructured":"Su Q, Kim SY, Adewale F, Zhou Y, Aldler C, Ni M, Wei Y. Single-cell RNA transcriptome landscape of hepatocytes and non-parenchymal cells in healthy and NAFLD mouse liver. iScience, 2021, 24:","journal-title":"iScience"},{"key":"CITATION61","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jhep.2024.03.014","volume":"81","author":"Yashaswini CN","year":"2024","unstructured":"Yashaswini CN, Qin T, Bhattacharya D, Amor C, Lowe S, Lujambio A, Wang S. Phenotypes and ontogeny of senescent hepatic stellate cells in metabolic dysfunction-associated steatohepatitis. J Hepatol, 2024, 81: 207-217.","journal-title":"J Hepatol"},{"key":"CITATION62","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s43018-022-00411-z","volume":"3","author":"Lavie D","year":"2022","unstructured":"Lavie D, Ben-Shmuel A, Erez N, Scherz-Shouval R. Cancer-associated fibroblasts in the single-cell era. Nat Cancer, 2022, 3: 793-807.","journal-title":"Nat Cancer"},{"key":"CITATION63","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.jcmgh.2023.01.006","volume":"15","author":"Ying F","year":"2023","unstructured":"Ying F, Chan MSM, Lee TKW. Cancer-associated fibroblasts in hepatocellular carcinoma and cholangiocarcinoma. Cell Mol Gastroenterol Hepatol, 2023, 15: 985-999.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"CITATION64","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","volume":"171","author":"Puram SV","year":"2017","unstructured":"Puram SV, Tirosh I, Parikh AS, Patel AP, Yizhak K, Gillespie S, Rodman C. Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell, 2017, 171: 1611-1624.e24.","journal-title":"Cell"},{"key":"CITATION65","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/s41388-021-02171-z","volume":"41","author":"Chiavarina B","year":"2022","unstructured":"Chiavarina B, Ronca R, Otaka Y, Sutton RB, Rezzola S, Yokobori T, Chiodelli P. Fibroblast-derived prolargin is a tumor suppressor in hepatocellular carcinoma. Oncogene, 2022, 41: 1410-1420.","journal-title":"Oncogene"},{"key":"CITATION66","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1084\/jem.20162024","volume":"214","author":"\u00d6hlund D","year":"2017","unstructured":"\u00d6hlund D, Handly-Santana A, Biffi G, Elyada E, Almeida AS, Ponz-Sarvise M, Corbo V. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J Exp Med, 2017, 214: 579-596.","journal-title":"J Exp Med"},{"key":"CITATION67","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.ccell.2024.08.011","volume":"42","author":"Cords L","year":"2024","unstructured":"Cords L, de Souza N, Bodenmiller B. Classifying cancer-associated fibroblasts\u2014the good, the bad, and the target. Cancer Cell, 2024, 42: 1480-1485.","journal-title":"Cancer Cell"},{"key":"CITATION68","doi-asserted-by":"publisher","first-page":"e146987","DOI":"10.1172\/JCI146987","volume":"131","author":"Bhattacharjee S","year":"2021","unstructured":"Bhattacharjee S, Hamberger F, Ravichandra A, Miller M, Nair A, Affo S, Filliol A. Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts. J Clin Invest, 2021, 131:","journal-title":"J Clin Invest"},{"key":"CITATION69","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","volume":"18","author":"Chen Y","year":"2021","unstructured":"Chen Y, McAndrews KM, Kalluri R. Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat Rev Clin Oncol, 2021, 18: 792-804.","journal-title":"Nat Rev Clin Oncol"},{"key":"CITATION70","doi-asserted-by":"publisher","first-page":"e008721","DOI":"10.1136\/jitc-2023-008721","volume":"12","author":"Wang H","year":"2024","unstructured":"Wang H, Liang Y, Liu Z, Zhang R, Chao J, Wang M, Liu M.  POSTN+ cancer-associated fibroblasts determine the efficacy of immunotherapy in hepatocellular carcinoma . J Immunother Cancer, 2024, 12:","journal-title":"J Immunother Cancer"},{"key":"CITATION71","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13045-019-0770-1","volume":"12","author":"Liu T","year":"2019","unstructured":"Liu T, Han C, Wang S, Fang P, Ma Z, Xu L, Yin R. Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy. J Hematol Oncol, 2019, 12:","journal-title":"J Hematol Oncol"},{"key":"CITATION72","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41419-024-07270-9","volume":"16","author":"Bai H","year":"2025","unstructured":"Bai H, Zhu X, Gao L, Feng S, Li H, Gu X, Xu J. ERG mediates the differentiation of hepatic progenitor cells towards immunosuppressive PDGFR\u03b1+ cancer-associated fibroblasts during hepatocarcinogenesis. Cell Death Dis, 2025, 16:","journal-title":"Cell Death Dis"},{"key":"CITATION73","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41421-023-00529-z","volume":"9","author":"Zhu GQ","year":"2023","unstructured":"Zhu GQ, Tang Z, Huang R, Qu WF, Fang Y, Yang R, Tao CY. CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor. Cell Discov, 2023, 9:","journal-title":"Cell Discov"},{"key":"CITATION74","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12943-023-01876-x","volume":"22","author":"Ma C","year":"2023","unstructured":"Ma C, Yang C, Peng A, Sun T, Ji X, Mi J, Wei L. Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment. Mol Cancer, 2023, 22:","journal-title":"Mol Cancer"},{"key":"CITATION75","doi-asserted-by":"publisher","first-page":"e011648","DOI":"10.1136\/jitc-2025-011648","volume":"13","author":"Xu W","year":"2025","unstructured":"Xu W, Weng J, Zhao Y, Xie P, Xu M, Liu S, Yu Q.  FMO2+ cancer-associated fibroblasts sensitize anti-PD-1 therapy in patients with hepatocellular carcinoma . J Immunother Cancer, 2025, 13:","journal-title":"J Immunother Cancer"},{"key":"CITATION76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41421-024-00747-z","volume":"11","author":"Cheng Y","year":"2025","unstructured":"Cheng Y, Chen X, Feng L, Yang Z, Xiao L, Xiang B, Wang X. Stromal architecture and fibroblast subpopulations with opposing effects on outcomes in hepatocellular carcinoma. Cell Discov, 2025, 11:","journal-title":"Cell Discov"},{"key":"CITATION77","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jhep.2007.06.021","volume":"48","author":"Yang F","year":"2008","unstructured":"Yang F, Yan S, He Y, Wang F, Song S, Guo Y, Zhou Q. Expression of hepatitis B virus proteins in transgenic mice alters lipid metabolism and induces oxidative stress in the liver. J Hepatol, 2008, 48: 12-19.","journal-title":"J Hepatol"},{"key":"CITATION78","doi-asserted-by":"publisher","first-page":"e1213","DOI":"10.1002\/ctm2.1213","volume":"13","author":"Li JH","year":"2023","unstructured":"Li JH, Wu X, Ni X, Li YX, Xu L, Hao XY, Zhao W. Angiotensin receptor blockers retard the progression and fibrosis via inhibiting the viability of AGTR1+ CAFs in intrahepatic cholangiocarcinoma. Clin Transl Med, 2023, 13:","journal-title":"Clin Transl Med"},{"key":"CITATION79","doi-asserted-by":"publisher","first-page":"101170","DOI":"10.1016\/j.drup.2024.101170","volume":"78","author":"Niu X","year":"2025","unstructured":"Niu X, You Q, Hou K, Tian Y, Wei P, Zhu Y, Gao B. Autophagy in cancer development, immune evasion, and drug resistance. Drug Resist Updat, 2025, 78:","journal-title":"Drug Resist Updat"},{"key":"CITATION80","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41568-019-0156-2","volume":"19","author":"Faget DV","year":"2019","unstructured":"Faget DV, Ren Q, Stewart SA. Unmasking senescence: context-dependent effects of SASP in cancer. Nat Rev Cancer, 2019, 19: 439-453.","journal-title":"Nat Rev Cancer"},{"key":"CITATION81","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1158\/2159-8290.CD-23-0428","volume":"14","author":"Belle JI","year":"2024","unstructured":"Belle JI, Sen D, Baer JM, Liu X, Lander VE, Ye J, Sells BE. Senescence defines a distinct subset of myofibroblasts that orchestrates immunosuppression in pancreatic cancer. Cancer Discov, 2024, 14: 1324-1355.","journal-title":"Cancer Discov"},{"key":"CITATION82","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13046-019-1172-5","volume":"38","author":"Yan Y","year":"2019","unstructured":"Yan Y, Chen X, Wang X, Zhao Z, Hu W, Zeng S, Wei J. The effects and the mechanisms of autophagy on the cancer-associated fibroblasts in cancer. J Exp Clin Cancer Res, 2019, 38:","journal-title":"J Exp Clin Cancer Res"},{"key":"CITATION83","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/leu.2015.289","volume":"30","author":"Frassanito MA","year":"2016","unstructured":"Frassanito MA, De Veirman K, Desantis V, Marzo LD, Vergara D, Ruggieri S, Annese T. Halting pro-survival autophagy by TGF\u03b2 inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients. Leukemia, 2016, 30: 640-648.","journal-title":"Leukemia"},{"key":"CITATION84","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ccell.2016.05.020","volume":"30","author":"Gomes AL","year":"2016","unstructured":"Gomes AL, Teijeiro A, Bur\u00e9n S, Tummala KS, Yilmaz M, Waisman A, Theurillat JP. Metabolic inflammation-associated IL-17A causes non-alcoholic steatohepatitis and hepatocellular carcinoma. Cancer Cell, 2016, 30: 161-175.","journal-title":"Cancer Cell"},{"key":"CITATION85","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41575-023-00821-z","volume":"20","author":"Cogliati B","year":"2023","unstructured":"Cogliati B, Yashaswini CN, Wang S, Sia D, Friedman SL. Friend or foe? The elusive role of hepatic stellate cells in liver cancer. Nat Rev Gastroenterol Hepatol, 2023, 20: 647-661.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"CITATION86","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s13046-023-02934-4","volume":"42","author":"Melchionna R","year":"2023","unstructured":"Melchionna R, Trono P, Di Carlo A, Di Modugno F, Nistic\u00f2 P. Transcription factors in fibroblast plasticity and CAF heterogeneity. J Exp Clin Cancer Res, 2023, 42:","journal-title":"J Exp Clin Cancer Res"},{"key":"CITATION87","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1016\/j.celrep.2019.07.092","volume":"28","author":"Bordignon P","year":"2019","unstructured":"Bordignon P, Bottoni G, Xu X, Popescu AS, Truan Z, Guenova E, Kofler L. Dualism of FGF and TGF-\u03b2 signaling in heterogeneous cancer-associated fibroblast activation with ETV1 as a critical determinant. Cell Rep, 2019, 28: 2358-2372.e6.","journal-title":"Cell Rep"},{"key":"CITATION88","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","volume":"9","author":"Biffi G","year":"2019","unstructured":"Biffi G, Oni TE, Spielman B, Hao Y, Elyada E, Park Y, Preall J. IL1-Induced JAK\/STAT signaling is antagonized by TGF\u03b2 to shape CAF heterogeneity in pancreatic ductal adenocarcinoma. Cancer Discov, 2019, 9: 282-301.","journal-title":"Cancer Discov"},{"key":"CITATION89","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1186\/s12967-024-05613-w","volume":"22","author":"Tong W","year":"2024","unstructured":"Tong W, Wang T, Bai Y, Yang X, Han P, Zhu L, Zhang Y. Spatial transcriptomics reveals tumor-derived SPP1 induces fibroblast chemotaxis and activation in the hepatocellular carcinoma microenvironment. J Transl Med, 2024, 22:","journal-title":"J Transl Med"},{"key":"CITATION90","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.stem.2014.01.005","volume":"14","author":"Pietras A","year":"2014","unstructured":"Pietras A, Katz AM, Ekstr\u00f6m EJ, Wee B, Halliday JJ, Pitter KL, Werbeck JL. Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth. Cell Stem Cell, 2014, 14: 357-369.","journal-title":"Cell Stem Cell"},{"key":"CITATION91","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.jhep.2020.06.004","volume":"73","author":"Saviano A","year":"2020","unstructured":"Saviano A, Henderson NC, Baumert TF. Single-cell genomics and spatial transcriptomics: discovery of novel cell states and cellular interactions in liver physiology and disease biology. J Hepatol, 2020, 73: 1219-1230.","journal-title":"J Hepatol"},{"key":"CITATION92","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.ccell.2025.03.004","volume":"43","author":"Liu Y","year":"2025","unstructured":"Liu Y, Sinjab A, Min J, Han G, Paradiso F, Zhang Y, Wang R. Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics. Cancer Cell, 2025, 43: 905-924.e6.","journal-title":"Cancer Cell"},{"key":"CITATION93","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1038\/s41467-023-39762-1","volume":"14","author":"Cords L","year":"2023","unstructured":"Cords L, Tietscher S, Anzeneder T, Langwieder C, Rees M, de Souza N, Bodenmiller B. Cancer-associated fibroblast classification in single-cell and spatial proteomics data. Nat Commun, 2023, 14:","journal-title":"Nat Commun"},{"key":"CITATION94","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s40364-022-00406-z","volume":"10","author":"Peng H","year":"2022","unstructured":"Peng H, Zhu E, Zhang Y. Advances of cancer-associated fibroblasts in liver cancer. Biomark Res, 2022, 10:","journal-title":"Biomark Res"},{"key":"CITATION95","doi-asserted-by":"publisher","first-page":"5534","DOI":"10.1038\/s41467-023-41095-y","volume":"14","author":"Omatsu M","year":"2023","unstructured":"Omatsu M, Nakanishi Y, Iwane K, Aoyama N, Duran A, Muta Y, Martinez-Ordo\u00f1ez A. THBS1-producing tumor-infiltrating monocyte-like cells contribute to immunosuppression and metastasis in colorectal cancer. Nat Commun, 2023, 14:","journal-title":"Nat Commun"},{"key":"CITATION96","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1053\/j.gastro.2017.03.046","volume":"153","author":"Ishimoto T","year":"2017","unstructured":"Ishimoto T, Miyake K, Nandi T, Yashiro M, Onishi N, Huang KK, Lin SJ. Activation of transforming growth factor beta 1 signaling in gastric cancer-associated fibroblasts increases their motility, via expression of rhomboid 5 homolog 2, and ability to induce invasiveness of gastric cancer cells. Gastroenterology, 2017, 153: 191-204.e16.","journal-title":"Gastroenterology"},{"key":"CITATION97","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13073-024-01367-8","volume":"16","author":"Jing SY","year":"2024","unstructured":"Jing SY, Liu D, Feng N, Dong H, Wang HQ, Yan X, Chen XF. Spatial multiomics reveals a subpopulation of fibroblasts associated with cancer stemness in human hepatocellular carcinoma. Genome Med, 2024, 16:","journal-title":"Genome Med"},{"key":"CITATION98","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1038\/s41598-024-52738-5","volume":"14","author":"Ma J","year":"2024","unstructured":"Ma J, Chen Z, Li Q, Wang L, Chen J, Yang X, Yang C. RARRES2 is involved in the \u201clock-and-key\u201d interactions between osteosarcoma stem cells and tumor-associated macrophages. Sci Rep, 2024, 14:","journal-title":"Sci Rep"},{"key":"CITATION99","doi-asserted-by":"publisher","first-page":"eaar3721","DOI":"10.1126\/scisignal.aar3721","volume":"11","author":"Cai B","year":"2018","unstructured":"Cai B, Kasikara C, Doran AC, Ramakrishnan R, Birge RB, Tabas I. MerTK signaling in macrophages promotes the synthesis of inflammation resolution mediators by suppressing CaMKII activity. Sci Signal, 2018, 11:","journal-title":"Sci Signal"},{"key":"CITATION100","doi-asserted-by":"publisher","first-page":"1240327","DOI":"10.3389\/fimmu.2023.1240327","volume":"14","author":"Kapanadze T","year":"2023","unstructured":"Kapanadze T, Gamrekelashvili J, Sablotny S, Kijas D, Haller H, Schmidt-Ott K, Limbourg FP. CSF-1 and Notch signaling cooperate in macrophage instruction and tissue repair during peripheral limb ischemia. Front Immunol, 2023, 14:","journal-title":"Front Immunol"},{"key":"CITATION101","doi-asserted-by":"publisher","first-page":"6500","DOI":"10.1038\/s41467-021-26770-2","volume":"12","author":"Wang Z","year":"2021","unstructured":"Wang Z, Li Z, Zhou K, Wang C, Jiang L, Zhang L, Yang Y. Deciphering cell lineage specification of human lung adenocarcinoma with single-cell RNA sequencing. Nat Commun, 2021, 12:","journal-title":"Nat Commun"},{"key":"CITATION102","doi-asserted-by":"publisher","first-page":"216985","DOI":"10.1016\/j.canlet.2024.216985","volume":"595","author":"Agorku DJ","year":"2024","unstructured":"Agorku DJ, Bosio A, Alves F, Str\u00f6bel P, Hardt O. Colorectal cancer-associated fibroblasts inhibit effector T cells via NECTIN2 signaling. Cancer Lett, 2024, 595:","journal-title":"Cancer Lett"},{"key":"CITATION103","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1002\/hep.31792","volume":"73","author":"Song M","year":"2021","unstructured":"Song M, He J, Pan QZ, Yang J, Zhao J, Zhang YJ, Huang Y. Cancer-associated fibroblast-mediated cellular crosstalk supports hepatocellular carcinoma progression. Hepatology, 2021, 73: 1717-1735.","journal-title":"Hepatology"},{"key":"CITATION104","doi-asserted-by":"publisher","first-page":"e12949","DOI":"10.1111\/eci.12949","volume":"48","author":"De Filippo K","year":"2018","unstructured":"De Filippo K, Rankin SM. CXCR 4, the master regulator of neutrophil trafficking in homeostasis and disease. Eur J Clin Invest, 2018, 48:","journal-title":"Eur J Clin Invest"},{"key":"CITATION105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/8239258","volume":"2016","author":"Sugimoto MA","year":"2016","unstructured":"Sugimoto MA, Vago JP, Teixeira MM, Sousa LP. Annexin A1 and the resolution of inflammation: modulation of neutrophil recruitment, apoptosis, and clearance. J Immunol Res, 2016, 2016: 1-13.","journal-title":"J Immunol Res"},{"key":"CITATION106","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41586-022-05400-x","volume":"612","author":"Xue R","year":"2022","unstructured":"Xue R, Zhang Q, Cao Q, Kong R, Xiang X, Liu H, Feng M. Liver tumour immune microenvironment subtypes and neutrophil heterogeneity. Nature, 2022, 612: 141-147.","journal-title":"Nature"},{"key":"CITATION107","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41571-021-00496-y","volume":"18","author":"Huinen ZR","year":"2021","unstructured":"Huinen ZR, Huijbers EJM, van Beijnum JR, Nowak-Sliwinska P, Griffioen AW. Anti-angiogenic agents\u2014overcoming tumour endothelial cell anergy and improving immunotherapy outcomes. Nat Rev Clin Oncol, 2021, 18: 527-540.","journal-title":"Nat Rev Clin Oncol"},{"key":"CITATION108","doi-asserted-by":"publisher","first-page":"1304183","DOI":"10.3389\/fimmu.2024.1304183","volume":"15","author":"Li J","year":"2024","unstructured":"Li J, Meng Z, Cao Z, Lu W, Yang Y, Li Z, Lu S. ADGRE5-centered Tsurv model in T cells recognizes responders to neoadjuvant cancer immunotherapy. Front Immunol, 2024, 15:","journal-title":"Front Immunol"},{"key":"CITATION109","doi-asserted-by":"publisher","first-page":"e006239","DOI":"10.1136\/jitc-2022-006239","volume":"11","author":"Zannikou M","year":"2023","unstructured":"Zannikou M, Duffy JT, Levine RN, Seblani M, Liu Q, Presser A, Arrieta VA. IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM. J Immunother Cancer, 2023, 11:","journal-title":"J Immunother Cancer"},{"key":"CITATION110","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s13287-022-02999-6","volume":"13","author":"Yu M","year":"2022","unstructured":"Yu M, Zhou M, Li J, Zong R, Yan Y, Kong L, Zhu Q. Notch-activated mesenchymal stromal\/stem cells enhance the protective effect against acetaminophen-induced acute liver injury by activating AMPK\/SIRT1 pathway. Stem Cell Res Ther, 2022, 13:","journal-title":"Stem Cell Res Ther"},{"key":"CITATION111","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.4161\/cc.8.23.10238","volume":"8","author":"Pavlides S","year":"2009","unstructured":"Pavlides S, Whitaker-Menezes D, Castello-Cros R, Flomenberg N, Witkiewicz AK, Frank PG, Casimiro MC. The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle, 2009, 8: 3984-4001.","journal-title":"Cell Cycle"},{"key":"CITATION112","doi-asserted-by":"publisher","first-page":"e2412740","DOI":"10.1002\/advs.202412740","volume":"12","author":"Zuyin L","year":"2025","unstructured":"Zuyin L, Zhao L, Qian C, Changkun Z, Delin M, Jialing H, Zhuomiaoyu C. Single-cell and spatial transcriptomics delineate the microstructure and immune landscape of intrahepatic cholangiocarcinoma in the leading-edge area. Adv Sci, 2025, 12:","journal-title":"Adv Sci"},{"key":"CITATION113","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ccell.2023.12.021","volume":"42","author":"Cords L","year":"2024","unstructured":"Cords L, Engler S, Haberecker M, R\u00fcschoff JH, Moch H, de Souza N, Bodenmiller B. Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer. Cancer Cell, 2024, 42: 396-412.e5.","journal-title":"Cancer Cell"},{"key":"CITATION114","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","volume":"9","author":"Elyada E","year":"2019","unstructured":"Elyada E, Bolisetty M, Laise P, Flynn WF, Courtois ET, Burkhart RA, Teinor JA. Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. Cancer Discov, 2019, 9: 1102-1123.","journal-title":"Cancer Discov"},{"key":"CITATION115","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.4251\/wjgo.v14.i10.1933","volume":"14","author":"Wang MQ","year":"2022","unstructured":"Wang MQ, Li YP, Xu M, Tian Y, Wu Y, Zhang X, Shi JJ. VCAN, expressed highly in hepatitis B virus-induced hepatocellular carcinoma, is a potential biomarker for immune checkpoint inhibitors. World J Gastrointest Oncol, 2022, 14: 1933-1948.","journal-title":"World J Gastrointest Oncol"},{"key":"CITATION116","doi-asserted-by":"publisher","first-page":"e64557","DOI":"10.7554\/eLife.64557","volume":"10","author":"Smith LK","year":"2021","unstructured":"Smith LK, Fawaz K, Treanor B. Galectin-9 regulates the threshold of B cell activation and autoimmunity. eLife, 2021, 10:","journal-title":"eLife"},{"key":"CITATION117","doi-asserted-by":"publisher","first-page":"1073672","DOI":"10.3389\/fonc.2022.1073672","volume":"12","author":"Mesini N","year":"2022","unstructured":"Mesini N, Fiorcari S, Atene CG, Maffei R, Potenza L, Luppi M, Marasca R. Role of Notch2 pathway in mature B cell malignancies. Front Oncol, 2022, 12:","journal-title":"Front Oncol"},{"key":"CITATION118","doi-asserted-by":"publisher","first-page":"e2505789122","DOI":"10.1073\/pnas.2505789122","volume":"122","author":"Chen P","year":"2025","unstructured":"Chen P, Geng H, Ma B, Zhang Y, Zhu Z, Li M, Chen S. Integrating spatial omics and single-cell mass spectrometry imaging reveals tumor-host metabolic interplay in hepatocellular carcinoma. Proc Natl Acad Sci USA, 2025, 122:","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION119","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","volume":"382","author":"Finn RS","year":"2020","unstructured":"Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim TY, Kudo M. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med, 2020, 382: 1894-1905.","journal-title":"N Engl J Med"},{"key":"CITATION120","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jhep.2021.11.030","volume":"76","author":"Cheng AL","year":"2022","unstructured":"Cheng AL, Qin S, Ikeda M, Galle PR, Ducreux M, Kim TY, Lim HY. Updated efficacy and safety data from IMbrave150: atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma. J Hepatol, 2022, 76: 862-873.","journal-title":"J Hepatol"},{"key":"CITATION121","doi-asserted-by":"publisher","first-page":"EVIDoa2100070","DOI":"10.1056\/EVIDoa2100070","volume":"1","author":"Abou-Alfa GK","year":"2022","unstructured":"Abou-Alfa GK, Lau G, Kudo M, Chan SL, Kelley RK, Furuse J, Sukeepaisarnjaroen W. Tremelimumab plus durvalumab in unresectable hepatocellular carcinoma. NEJM Evid, 2022, 1:","journal-title":"NEJM Evid"},{"key":"CITATION122","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1039\/D2TB02253B","volume":"11","author":"Shen W","year":"2023","unstructured":"Shen W, Yao P, Li W, Gu C, Gao T, Cao Y, Wang Z. Cancer-associated fibroblast-targeted nanodrugs reshape colorectal tumor microenvironments to suppress tumor proliferation, metastasis and improve drug penetration. J Mater Chem B, 2023, 11: 1871-1880.","journal-title":"J Mater Chem B"},{"key":"CITATION123","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.bbadis.2017.12.021","volume":"1864","author":"Yi Y","year":"2018","unstructured":"Yi Y, Zeng S, Wang Z, Wu M, Ma Y, Ye X, Zhang B. Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF\/IGF-1\/ANXA2 signaling. Biochim Biophys Acta Mol Basis Dis, 2018, 1864: 793-803.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"CITATION124","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/cac2.12414","volume":"43","author":"Eun JW","year":"2023","unstructured":"Eun JW, Yoon JH, Ahn HR, Kim S, Kim YB, Lim SB, Park W. Cancer-associated fibroblast-derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib. Cancer Commun, 2023, 43: 455-479.","journal-title":"Cancer Commun"},{"key":"CITATION125","doi-asserted-by":"publisher","first-page":"100960","DOI":"10.1016\/j.drup.2023.100960","volume":"68","author":"Qi R","year":"2023","unstructured":"Qi R, Bai Y, Li K, Liu N, Xu Y, Dal E, Wang Y. Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs. Drug Resist Updat, 2023, 68:","journal-title":"Drug Resist Updat"},{"key":"CITATION126","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-020-01168-8","volume":"19","author":"Zhang H","year":"2020","unstructured":"Zhang H, Deng T, Liu R, Ning T, Yang H, Liu D, Zhang Q. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol Cancer, 2020, 19:","journal-title":"Mol Cancer"},{"key":"CITATION127","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jhep.2013.09.013","volume":"60","author":"Stewart RK","year":"2014","unstructured":"Stewart RK, Dangi A, Huang C, Murase N, Kimura S, Stolz DB, Wilson GC. A novel mouse model of depletion of stellate cells clarifies their role in ischemia\/reperfusion- and endotoxin-induced acute liver injury. J Hepatol, 2014, 60: 298-305.","journal-title":"J Hepatol"},{"key":"CITATION128","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/hep.26053","volume":"57","author":"Puche JE","year":"2013","unstructured":"Puche JE, Lee YA, Jiao J, Aloman C, Fiel MI, Mu\u00f1oz U, Kraus T. A novel murine model to deplete hepatic stellate cells uncovers their role in amplifying liver damage in mice. Hepatology, 2013, 57: 339-350.","journal-title":"Hepatology"},{"key":"CITATION129","doi-asserted-by":"publisher","first-page":"eadf6696","DOI":"10.1126\/scisignal.adf6696","volume":"16","author":"Trinh VQH","year":"2023","unstructured":"Trinh VQH, Lee TF, Lemoinne S, Ray KC, Ybanez MD, Tsuchida T, Carter JK. Hepatic stellate cells maintain liver homeostasis through paracrine neurotrophin-3 signaling that induces hepatocyte proliferation. Sci Signal, 2023, 16:","journal-title":"Sci Signal"},{"key":"CITATION130","doi-asserted-by":"publisher","first-page":"eabl7209","DOI":"10.1126\/sciimmunol.abl7209","volume":"7","author":"Yamagishi R","year":"2022","unstructured":"Yamagishi R, Kamachi F, Nakamura M, Yamazaki S, Kamiya T, Takasugi M, Cheng Y. Gasdermin D\u2013mediated release of IL-33 from senescent hepatic stellate cells promotes obesity-associated hepatocellular carcinoma. Sci Immunol, 2022, 7:","journal-title":"Sci Immunol"},{"key":"CITATION131","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1038\/nm.3282","volume":"19","author":"Henderson NC","year":"2013","unstructured":"Henderson NC, Arnold TD, Katamura Y, Giacomini MM, Rodriguez JD, McCarty JH, Pellicoro A. Targeting of \u03b1v integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nat Med, 2013, 19: 1617-1624.","journal-title":"Nat Med"},{"key":"CITATION132","doi-asserted-by":"publisher","first-page":"11006","DOI":"10.1038\/s41598-017-11212-1","volume":"7","author":"Wu MH","year":"2017","unstructured":"Wu MH, Chen YL, Lee KH, Chang CC, Cheng TM, Wu SY, Tu CC. Glycosylation-dependent galectin-1\/neuropilin-1 interactions promote liver fibrosis through activation of TGF-\u03b2- and PDGF-like signals in hepatic stellate cells. Sci Rep, 2017, 7:","journal-title":"Sci Rep"},{"key":"CITATION133","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/cr.2015.60","volume":"25","author":"He K","year":"2015","unstructured":"He K, Yan X, Li N, Dang S, Xu L, Zhao B, Li Z. Internalization of the TGF-\u03b2 type I receptor into caveolin-1 and EEA1 double-positive early endosomes. Cell Res, 2015, 25: 738-752.","journal-title":"Cell Res"},{"key":"CITATION134","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/hep.22731","volume":"49","author":"Fransvea E","year":"2009","unstructured":"Fransvea E, Mazzocca A, Antonaci S, Giannelli G. Targeting transforming growth factor (TGF)-\u03b2RI inhibits activation of \u03b21 integrin and blocks vascular invasion in hepatocellular carcinoma. Hepatology, 2009, 49: 839-850.","journal-title":"Hepatology"},{"key":"CITATION135","doi-asserted-by":"publisher","first-page":"eaat9284","DOI":"10.1126\/scitranslmed.aat9284","volume":"11","author":"Yang YM","year":"2019","unstructured":"Yang YM, Noureddin M, Liu C, Ohashi K, Kim SY, Ramnath D, Powell EE. Hyaluronan synthase 2-mediated hyaluronan production mediates Notch1 activation and liver fibrosis. Sci Transl Med, 2019, 11:","journal-title":"Sci Transl Med"},{"key":"CITATION136","doi-asserted-by":"publisher","first-page":"16552","DOI":"10.1038\/srep16552","volume":"5","author":"Li HY","year":"2015","unstructured":"Li HY, Ju D, Zhang DW, Li H, Kong LM, Guo Y, Li C. Activation of TGF-\u03b21-CD147 positive feedback loop in hepatic stellate cells promotes liver fibrosis. Sci Rep, 2015, 5:","journal-title":"Sci Rep"},{"key":"CITATION137","doi-asserted-by":"publisher","first-page":"18270","DOI":"10.1074\/jbc.M114.562249","volume":"289","author":"Desai LP","year":"2014","unstructured":"Desai LP, Zhou Y, Estrada AV, Ding Q, Cheng G, Collawn JF, Thannickal VJ. Negative regulation of NADPH oxidase 4 by hydrogen peroxide-inducible clone 5 (Hic-5) protein. J Biol Chem, 2014, 289: 18270-18278.","journal-title":"J Biol Chem"},{"key":"CITATION138","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1158\/1535-7163.MCT-16-0589","volume":"16","author":"Perera TPS","year":"2017","unstructured":"Perera TPS, Jovcheva E, Mevellec L, Vialard J, De Lange D, Verhulst T, Paulussen C. Discovery and pharmacological characterization of JNJ-42756493 (Erdafitinib), a functionally selective small-molecule FGFR family inhibitor. Mol Cancer Ther, 2017, 16: 1010-1020.","journal-title":"Mol Cancer Ther"},{"key":"CITATION139","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12885-016-2162-z","volume":"16","author":"Mediavilla-Varela M","year":"2016","unstructured":"Mediavilla-Varela M, Boateng K, Noyes D, Antonia SJ. The anti-fibrotic agent pirfenidone synergizes with cisplatin in killing tumor cells and cancer-associated fibroblasts. BMC Cancer, 2016, 16:","journal-title":"BMC Cancer"},{"key":"CITATION140","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1158\/0008-5472.CAN-12-2130","volume":"73","author":"Mertens JC","year":"2013","unstructured":"Mertens JC, Fingas CD, Christensen JD, Smoot RL, Bronk SF, Werneburg NW, Gustafson MP. Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma. Cancer Res, 2013, 73: 897-907.","journal-title":"Cancer Res"},{"key":"CITATION141","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1158\/0008-5472.CAN-17-2268","volume":"78","author":"Karakasheva TA","year":"2018","unstructured":"Karakasheva TA, Lin EW, Tang Q, Qiao E, Waldron TJ, Soni M, Klein-Szanto AJ. IL-6 mediates cross-talk between tumor cells and activated fibroblasts in the tumor microenvironment. Cancer Res, 2018, 78: 4957-4970.","journal-title":"Cancer Res"},{"key":"CITATION142","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1038\/s41467-021-24687-4","volume":"12","author":"Wang W","year":"2021","unstructured":"Wang W, Tang YA, Xiao Q, Lee WC, Cheng B, Niu Z, Oguz G. Stromal induction of BRD4 phosphorylation results in chromatin remodeling and BET inhibitor resistance in colorectal cancer. Nat Commun, 2021, 12:","journal-title":"Nat Commun"},{"key":"CITATION143","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1158\/1078-0432.CCR-17-2033","volume":"24","author":"Duperret EK","year":"2018","unstructured":"Duperret EK, Trautz A, Ammons D, Perales-Puchalt A, Wise MC, Yan J, Reed C. Alteration of the tumor stroma using a consensus DNA vaccine targeting fibroblast activation protein (FAP) synergizes with antitumor vaccine therapy in mice. Clin Cancer Res, 2018, 24: 1190-1201.","journal-title":"Clin Cancer Res"},{"key":"CITATION144","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1158\/0008-5472.CAN-14-3041","volume":"75","author":"Lo A","year":"2015","unstructured":"Lo A, Wang LCS, Scholler J, Monslow J, Avery D, Newick K, O\u2032Brien S. Tumor-promoting desmoplasia is disrupted by depleting FAP-expressing stromal cells. Cancer Res, 2015, 75: 2800-2810.","journal-title":"Cancer Res"},{"key":"CITATION145","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40425-019-0505-4","volume":"7","author":"de Sostoa J","year":"2019","unstructured":"de Sostoa J, Fajardo CA, Moreno R, Ramos MD, Farrera-Sal M, Alemany R. Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager. J Immunother Cancer, 2019, 7:","journal-title":"J Immunother Cancer"},{"key":"CITATION146","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1136\/gutjnl-2025-335084","volume":"75","author":"Prawira A","year":"2026","unstructured":"Prawira A, Xu H, Mei Y, Leow WQ, Nasir NJM, Reolo MJ, Otsuka M. Targeting Treg-fibroblast interaction to enhance immunotherapy in steatotic liver disease-related hepatocellular carcinoma. Gut, 2026, 75: 105-118.","journal-title":"Gut"},{"key":"CITATION147","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.bbrc.2017.02.128","volume":"486","author":"Liu H","year":"2017","unstructured":"Liu H, Shen J, Lu K. IL-6 and PD-L1 blockade combination inhibits hepatocellular carcinoma cancer development in mouse model. Biochem Biophys Res Commun, 2017, 486: 239-244.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/0F91FD7AAC54439987A24AFD3B2BD9D7","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026138","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/0F91FD7AAC54439987A24AFD3B2BD9D7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:21:24Z","timestamp":1789971684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":147,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,8,14]]},"published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.3724\/abbs.2026138","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,14]]}}}